The Leukemia/Bone Marrow Transplant Program is staffed by a team of dedicated and experienced physicians. The Leukemia/BMT Program currently has 15 senior staff. Click our links to the left to learn more about each doctor.

Medical Director, Leukemia/BMT Program of BC

Dr. Sujaatha Narayanan trained as a Hematologist and completed a Bone Marrow Transplant Fellowship in the United Kingdom before moving to Canada in 2006. She then completed a second Fellowship in Leukemia and Stem Cell Transplantation at Vancouver before joining the Leukemia/BMT Program of BC as an Attending Physician in December 2007.

Dr Narayanan has held a number of leadership positions within LBMT, including being the Quality director, Program fellowship director and has successfully lead the program through a number of quality initiatives aimed at improving various aspects of patient care in the program. She has been the Medical Director of the program since December 2018. Dr. Narayanan has clinical and research interest in AML, MDS and cellular therapy.

Associate Medical Director, Leukemia/BMT Program of BC

Dr. Maryse Power trained as a haematologist in Ireland, completing the Higher Medical Training Scheme in Hematology. She worked as Lecturer in Hematology in St James Hospital Dublin and Trinity College Dublin 2004-2005 before moving to Canada in August 2005. She completed fellowship in Leukemia and Stem Cell Transplant with the Leukemia and BMT Program of BC before joining the attending physician staff in July 2007.

Her research interests include acute myeloid leukemia, myelodysplasia, stem cell transplant therapy for relapsed Hodgkins Lymphoma and the management of opportunistic infections following high dose chemotherapy and stem cell transplantation.

Hematologist, Leukemia/BMT Program of BC

Dr. Yasser Abou Mourad trained in Internal Medicine, Medical Oncology/Hematology at the American University of Beirut before   joining the Leukemia/BMT Program of British Columbia in 2004. Dr. Abou Mourad is currently the program director of the L/BMT Fellowship and Training. He has particular interest in transplantation, in acute lymphoblastic leukemia (ALL) treatment and in applying pediatric protocols to adult ALL patients. 

Dr. Abou Mourad is an active NCI and NCIC researcher taking part in multiple prospective national and international trials. He is an author of more than forty publications in peer reviewed respected journals.  Dr. Abou Mourad has published on adult ALL therapy and been invited to speak on this topic regionally, nationally, and internationally. 

Hematologist, Leukemia/BMT Program of BC

Dr. Donna Forrest joined the Leukemia/BMT Program of BC in September 2002. She was previously a Hematologist at Dalhousie University in Halifax and member of the BMT Program of Atlantic Canada (1998-2002). Her current research endeavours include the management of chronic myeloid leukemia as well as late effects following bone marrow transplant, particularly the development of second malignancies.

Hematologist, Leukemia/BMT Program of BC | Scientist, Terry Fox Laboratory, BC Cancer Research Institute | Assistant Professor, Department of Medicine, University of British Columbia | Director, Clinical Cellular Therapy Laboratory, BC Cancer | Medical Director, Conconi Family Immunotherapy Laboratory, BC Cancer

Dr. Kevin Hay is a Clinician Scientist at the Terry Fox Laboratory and Leukemia/Bone Marrow Transplant Program of BC in Vancouver. Dr. Hay received a Master of Science in Immunology at the University of Manitoba (2008), followed by an MD (2011). After completing residency in Internal Medicine (2014) and a clinical fellowship in Haematology (2016) at the University of British Columbia, he was awarded a scholarship through the Clinician Investigator Program of UBC to pursue a postdoctoral fellowship in cellular immunotherapy which he completed at the Fred Hutchinson Cancer Research Center in Seattle Washington under the mentorship of Dr. Cameron Turtle. Dr. Hay’s research focuses on understanding the unique toxicities associated with Chimeric Antigen Receptor (CAR)-T cells, as well as the development of novel CAR-T cell therapies. He is Director of the BC Cancer Clinical Cellular Therapy Laboratory where he oversees the processing of cells for hematopoietic cell transplantation. He also serves as Medical Director of the Conconi Family Immunotherapy Laboratory, a facility in British Columbia dedicated to the manufacturing of cellular immunotherapies, and is Principal Investigator on Phase I/II trials in Canada using CAR-T cells.

Hematologist, Leukemia/BMT Program of BC

Dr. Florian Kuchenbauer received his M.D. education at the Ludwig-Maximilians-University in Munich and trained at the Department of Hematology/Oncology, Klinikum Grosshadern, Munich at the university hospital in Ulm, Germany. In addition, he obtained a PhD degree at the Terry Fox Laboratory, BC Cancer and Department of Experimental Medicine, University of British Columbia where he work as clinician-scientist with a special clinical interest in acute myeloid leukemia (AML) and stem cell transplantation. His research group as part of the Terry Fox Laboratory focuses on establishing novel treatments for AML and multiple myeloma.

Hematologist, Leukemia/BMT Program of BC

Dr. Stephen Nantel joined the Leukemia/Bone Marrow Transplant Program in 1991 and his research interests have included the development of multi-agent chemotherapy regimens for acute myelogenous leukemia (AML) and acute lymphoblastic leukemia (ALL). In 2013, Dr. Nantel assumed the role of Division Head, UBC Hematology.

Dr. Nantel also has a general hematology practice and, as a former Training Program Director and Chief Examiner for the Royal College of Physicians and Surgeons of Canada, has a special interest in Hematology education and certification.

Hematologist, Leukemia/BMT Program of BC

Dr. Thomas Nevill founded the Bone Marrow Transplant Program of Atlantic Canada in 1991 and acted as its Director for five years. He joined the Leukemia/Bone Marrow Transplant Program of BC in 1996.

His research interests include prognostic factors and new therapies in myelodysplastic syndrome (MDS), prevention and treatment of graft-versus-host disease (GVHD), and attempting to reduce the psychological impact of bone marrow transplant on patients and families.

Hematologist, Leukemia/BMT Program of BC

Dr. Judith Rodrigo hails from Ontario, but completed her undergraduate studies at McGill University in Montreal, and undergraduate medicine at the University of Alberta. After coming to Vancouver to complete her Internal Medicine and Hematology training, she joined the Leukemia/BMT program in 2010 .  Dr. Rodrigo’s interests include improving supportive and palliative care for leukemia and transplant patients, and the evolving role for CART cell therapies for these patients.

Hematologist, Leukemia/BMT Program of BC

Dr. David Sanford joined the Leukemia/BMT Program of BC in September 2015.  He previously completed training in Hematology at the University of Western Ontario.  Following this, he undertook a Leukemia Fellowship at MD Anderson Cancer Center in Houston, Texas.  He has interests in clinical research in acute myeloid leukemia, including the development of molecularly targeted therapies as well as the role of minimal residual disease in guiding treatment.

Hematologist, Leukemia/BMT Program of BC

Dr Matthew Seftel is a clinical professor in the division of Hematology at the University of British Columbia.  He is originally from South Africa, where he qualified in Medicine from the University of Cape Town. He has specialist training in Internal Medicine, Hematology and BMT from the UK and Canada. He also holds post-graduate training in Public Health from the Johns Hopkins University. His clinical, teaching, and research interests are in complex hematological malignancies and Blood and Marrow Transplant (BMT)/cellular therapy.    He is an active investigator with the Canadian Clinical Trials Group (CCTG) and the Centre for International Blood and Marrow Transplant Research (CIBMTR).

Hematologist, Leukemia/BMT Program of BC

Dr. Kevin Song trained in Hematology and then as a Leukemia/Bone Marrow Transplant Fellow in Vancouver from 1998-2000. He did further bone marrow transplant training in Toronto before joining the Leukemia/Bone Marrow Transplant Program Attending Staff in August 2002. His current interests include the treatment of myeloma and other plasma cell dyscrasias and the use of hematopoietic stem cell transplant to treat non-Hodgkin’s lymphoma.

Hematologist, Leukemia/BMT Program of BC

Dr. Heather Sutherland did her undergraduate training at the University of Saskatchewan, her clinical hematology fellowship at the University of Toronto, followed by a PhD at the Terry Fox Laboratory, University of British Columbia from 1986-1989. She has been a staff physician at the Vancouver General Hospital since 1990 and an Attending Leukemia and Bone Marrow Transplant Staff Physician since 1991. Her clinical practice is now exclusively;in this area with a focus on the treatment of patients with multiple myeloma.

Dr. Sutherland has a special interest in clinical trials of new myeloma therapies and in the development of novel therapies for multiple myeloma in the laboratory.

Hematologist, Leukemia/BMT Program of BC

Dr. Cynthia Toze completed her Hematology and Leukemia/Bone Marrow Transplant training in Vancouver and joined the Attending Staff after completing her Masters in Epidemiology at UBC in 1995. She has been active in clinical trials with the Canadian Blood and Marrow Transplant Group and led CLL research related database development in BC.

Her research has included the study of chronic lymphocytic leukemia and the use of allogeneic (donor) bone marrow transplants to treat chronic lymphocytic leukemia and low-grade (indolent) lymphomas.

Hematologist, Leukemia/BMT Program of BC

Dr. Jennifer White joined the Leukemia/BMT Program of BC as an attending physician in July 2017. She completed her Master of Science in Epidemiology from Queen’s University and her medical training at McMaster University and the University of British Columbia. She then completed the Leukemia/BMT Program of BC fellowship from 2015-2017 with additional training at the Fred Hutchinson Cancer Research Centre in Seattle in Chronic Graft vs Host Disease management and late effects post allogeneic transplant. She has clinical and research interests in the prevention and management of Graft vs Host Disease, quality of life following allogeneic stem cell transplant and in service delivery in leukemia and transplant care.

Senior BMT Attending, Leukemia/BMT Program of BC

Dr. Shanee Chung received her Bachelor of Medicine and Surgery from University of Auckland in New Zealand in 2010.  She subsequently completed conjoint training in clinical hematology and hematopathology and gained entrance to the Fellowship of the Royal Australasian College of Physicians and the Royal College of Pathologists of Australasia.  She undertook additional training as a clinical and research fellow in the Leukemia/Bone Marrow Transplant Program of B.C. in Vancouver from 2018 to 2020.  Her main research interests include malignant myeloid disorders and acute leukemias.